ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,386, issued on April 21, was assigned to APR Applied Pharma Research SA (Balerna, Switzerland).
"Sapropterin formulation" was invented by Christopher Wagstaff (Cambridge, Great Britain) and Stephen Tickle (Cheshire, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a formulation of sapropterin. The formulation comprises a solid suspension of sapropterin dispersed within an oil. Methods of treatment using the formulation are also contemplated by the present disclosure."
The patent was filed on July 16, 2025, under Application No. 19/271,410.
*For further information, including images, charts and tables,...